<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/channel/SITC/videoEmbed/39611/jacob-adashek-do-jacobadashek-usouthflorida-moffittnews-dr_r_kurzrock-alexeygoloubev-sitc20-carcinomas-immunotherapy-trials-lack-a-biomarker-for-inclusion-implications-for-drug-d...?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immuno...

00:04:09

Jennifer

3 years 71 Views

Share Add to Report 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/channel/SITC/videoEmbed/39611/jacob-adashek-do-jacobadashek-usouthflorida-moffittnews-dr_r_kurzrock-alexeygoloubev-sitc20-carcinomas-immunotherapy-trials-lack-a-biomarker-for-inclusion-implications-for-drug-d...?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/channel/SITC/videoEmbed/39611/jacob-adashek-do-jacobadashek-usouthflorida-moffittnews-dr_r_kurzrock-alexeygoloubev-sitc20-carcinomas-immunotherapy-trials-lack-a-biomarker-for-inclusion-implications-for-drug-d...?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/channel/SITC/videoEmbed/39611/jacob-adashek-do-jacobadashek-usouthflorida-moffittnews-dr_r_kurzrock-alexeygoloubev-sitc20-carcinomas-immunotherapy-trials-lack-a-biomarker-for-inclusion-implications-for-drug-d...?modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/channel/SITC/video/39611"><img src="https://oncologytubecom.cdn.ypt.me/view/img/video-placeholder-gray-portrait.webp?cache=1693571832_1693571832">Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...</a>

Link (BBCode):

[url=https://oncologytube.com/channel/SITC/video/39611][img]https://oncologytubecom.cdn.ypt.me/view/img/video-placeholder-gray-portrait.webp?cache=1693571832_1693571832[/img]Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Immunotherapy

Description:

Jacob Adashek, DO of The University of South Florida and H. Lee Moffitt Cancer Center & Research Institute discusses the Poster Presentation Immunotherapy trials lack a biomarker for inclusion: implications for drug development.

Poster Presentation #179

Immunotherapy research lacks a biomarker for inclusion: drug discovery implications.

Co-Authored by Alexey Goloubev; Shumei Kato, MD; Razelle Kurzrock, MD.